US biopharma Mineralys Therapeutics has announced positive topline data from its Phase II Explore-CKD trial evaluating the ...

US pharma major AbbVie (NYSE: ABBV) today announced positive top-line results from its Phase III TEMPLE multicenter, ...

EY today released its 35th annual Biotech Beyond Borders Report. This finds that the biopharma industry is currently at an ...

The UK’s National Institute for Health and Care Excellence (NICE) has today recommended Spevigo (spesolimab) for the ...

Japanese companies Axcelead and A2 Healthcare Corporation announced that they will enter a strategic partnership to promote ...

US pharma firm Lisata Therapeutics (Nasdaq: LSTA) has teamed up with tech-bio company GATC Health in a strategic alliance ...

The US Food and Drug Administration has announced the Commissioner’s National Priority Voucher (CNPV) program aimed at ...

US biotech Dyne Therapeutics (Nasdaq: DYN) has revised its regulatory approach for DYNE-101, a treatment in development for ...

Draig Therapeutics, a clinical-stage company based in Cardiff, UK, and aiming to transform the treatment of neuropsychiatric ...

Japanese companies NEC Corporation and Chugai Pharmaceutical have entered a collaboration to conduct an experiment using AI ...

A controversial proposal to change the Inflation Reduction Act’s pricing framework for rare disease drugs has been dropped ...

SunRock Biopharma has teamed up with China’s Escugen to co-develop SRB123, a first-in-class antibody-drug conjugate (ADC) targeting CCR9, an antigen which is tied to particularly hard-to-treat cancers ...